LPL Financial’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
VCM
MCM
TSC
PCM
LPL Financial's LUCD Position: Q1 2026 in Review
LPL Financial increased its Lucid Diagnostics (LUCD) stake by 22% in Q1 2026, buying an estimated $39.4K and bringing the position to 172,376 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #5499.
LPL Financial first reported a position in LUCD in Q2 2022 and has held it in 16 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.
- LPL Financial held 172,376 shares of Lucid Diagnostics worth $198K as of Q1 2026.
- LPL Financial bought 30,985 Lucid Diagnostics shares in Q1 2026, an estimated $39.4K.
- Lucid Diagnostics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5499 holding.
- LPL Financial first reported a position in Lucid Diagnostics in Q2 2022 and has held it in 16 quarters since.
- 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.